http://chronicmyeloidleukemia.cancerbasics.info/Chronic Myeloid Leukemia Newsfeed. News for chronic myeloid leukemia last updated on Fri, 2 Jan 2009 14:12:24 +0100.en-uscancerbasics.info@gmail.comFri, 2 Jan 2009 14:12:24 +0100Fri, 2 Jan 2009 14:12:24 +0100Healthhttp://blogs.law.harvard.edu/tech/rss60http://media.tbrss.info/sites/010025/feedfavicon.pnghttp://chronicmyeloidleukemia.cancerbasics.info/Chronic Myeloid Leukemia Newsfeed. News for chronic myeloid leukemia last updated on Fri, 2 Jan 2009 14:12:24 +0100.8888http://news.cancerbasics.info/linkout/ocml.php?out=http://www.highbeam.com/doc/1G1-128876058.htmlSAN DIEGO - A new oral drug for patients with Gleevec-resistant chronic myeloid leukemia led to remission in 86% of patients in a phase I trial. Obviously we're excited by that, Charles L. Sawyers, M.D., said at a press briefing during the annual meeting of the American Society of Hematology. The ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=56973336><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=56973336&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=56973336 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>http://www.rsscache.com/Section/Advertise/click.aspx?a=19452184Amazing Chinese Weight Loss Secret.&#13;&#10;As Seen On CNN, NBC, CBS & Fox.http://news.cancerbasics.info/linkout/ocml.php?out=http://www.highbeam.com/doc/1G1-53552107.htmlChronic leukemias of myeloid origin disorders are the second major category of chronic leukemias. The first major category of chronic leukemias, leukemias of lymphoid origin, was discussed in part one of this two-part series . This group of neoplastic disorders ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=56973335><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=56973335&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=56973335 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>http://news.cancerbasics.info/linkout/ocml.php?out=http://www.highbeam.com/doc/1G1-97783930.htmlM2 PRESSWIRE-18 February 2003-Research and Markets: Chronic Myeloid Leukemia - Gleevec resistance is opening a market for synergistic use1994-2003 M2 COMMUNICATIONS LTD RDATE:02152003 With CML`s relatively low prevalence, the potential market for drugs launched for this indication historically ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=56973334><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=56973334&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=56973334 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>http://news.cancerbasics.info/linkout/ocml.php?out=http://www.highbeam.com/doc/1P3-1514322251.htmlIntroduction Chronic myeloid leukemia is a clonal stem cell disorder associated with the reciprocal translocation between chromosomes 9 and 22 resulting in formation of the bcr-abl chimeric protein with tyrosine kinase activity. [1] The enhanced tyrosine kinase activity has been ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=56973333><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=56973333&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=56973333 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>ATLANTA - Based on input from an expert advisory panel, the oral tyrosine kinase inhibitor dasatinib may be approved by the Food and Drug Administration for the treatment of imatinib-resistant or -intolerant adults with chronic myeloid leukemia. Other potential indications include treatment of ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=50982850><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=50982850&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=50982850 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>Sir, Imatinib mesylate has revolutionized the treatment of chronic myeloid leukemia and has been recently approved as first-line treatment. Most of the patients receiving imatinib experience hematological or non-hematological side effects. Skin changes are the most common non-hematological ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=50067864><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=50067864&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=50067864 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>SAN DIEGO - A new oral drug for patients with Gleevec-resistant chronic myeloid leukemia led to remission in 86% of patients in a phase I trial. Obviously we're excited by that, Charles L. Sawyers, M.D., said at a press briefing during the annual meeting of the American Society of Hematology. The ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=50067863><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=50067863&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=50067863 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>M2 PRESSWIRE-18 February 2003-Research and Markets: Chronic Myeloid Leukemia - Gleevec resistance is opening a market for synergistic use1994-2003 M2 COMMUNICATIONS LTD RDATE:02152003 With CML`s relatively low prevalence, the potential market for drugs launched for this indication historically ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=50067862><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=50067862&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=50067862 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>Introduction Chronic myeloid leukemia is a clonal stem cell disorder associated with the reciprocal translocation between chromosomes 9 and 22 resulting in formation of the bcr-abl chimeric protein with tyrosine kinase activity. [1] The enhanced tyrosine kinase activity has been ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=50067861><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=50067861&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=50067861 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>Chronic myeloid leukemia provides an illustrative disease model for both molecular pathogenesis of cancer and rational drug therapy. Chronic myeloid leukemia is a clonal stem cell disease caused by an acquired somatic mutation that fuses, through chromosomal translocation, the abl and bcr genes on ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=49613046><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=49613046&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=49613046 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>Chronic myeloid leukemia has become a model in research and management among malignant disorders. Since the discovery of the presence of a unique and constant chromosomal abnormality slightly more than 40 years ago, substantial progress has been made in the understanding of the biology of the ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=49613045><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=49613045&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=49613045 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>http://www.rsscache.com/Section/Advertise/click.aspx?a=19452185I cut out 2 lbs of stomach fat per week by obeying this 1 old ruleChronic leukemias of myeloid origin disorders are the second major category of chronic leukemias. The first major category of chronic leukemias, leukemias of lymphoid origin, was discussed in part one of this two-part series . This group of neoplastic disorders ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=49613044><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=49613044&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=49613044 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>Background: Despite the efficacy of the BCR-ABL tyrosine kinase inhibitor Imatinib mesylate for the treatment of chronic myeloid leukemia , resistance has been observed in a proportion of cases, especially those with advanced stages of the disease. Point mutations within the ABL kinase domain ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=49613043><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=49613043&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=49613043 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>- Tasigna produced responses in 40% of patients with Philadelphia chromosome-positive chronic myeloid leukemia resistant or intolerant to prior treatment - Approval and availability in US means Novartis can offer physicians and patients a comprehensive treatment approach for this disease EAST ...<p><a href=http://www.rsscache.com/Section/Advertise/click.aspx?n=49613042><img src="http://www.rsscache.com/Section/Advertise/ads.aspx?n=49613042&f=49985" border=0></a><p><div style="font-size: 8pt;"><img align=left src=http://www.rsscache.com/Section/Stats/logo.aspx?n=49613042 border=0> Bandwidth saved by <a href=http://www.rsscache.com>RSScache.com</a></div>49985